Overview
Lorymed contains levetiracetam, an antiepileptic medicine, in film-coated tablets of 250 mg and 500 mg. It is a prescription-only medicine manufactured by Welmed Pharmaceutical Industries, Gadoon.
Tablets
Lorymed
Lorymed is part of the YS Pharma (PVT) Limited product portfolio.
- Active ingredient
- Levetiracetam
- Strengths
- 250 mg and 500 mg
- Dosage form
- Film-coated tablet
- DRAP Reg. No.
- 110110 (250 mg), 108533 (500 mg)
- Manufacturer
- Welmed Pharmaceutical Industries (Pvt) Ltd, Gadoon
- Supply
- To be sold on the prescription of a registered medical practitioner only (pack)
Read the full product information below, or ask our team for more details.
Product listings on this website are provided for identification and business inquiries only. They are not medical advice. Please consult a qualified healthcare professional.
Product Information
Lorymed
Composition
Each film-coated tablet contains:
| Ingredient | Amount | Unit |
|---|---|---|
| Levetiracetam (Lorymed 250 mg) | 250 | mg |
| Levetiracetam (Lorymed 500 mg) | 500 | mg |
Manufactured to USP specifications (pack label).
Indications & Uses
Lorymed is a prescription medicine. Its approved indications are set out in the DRAP-approved package insert. In line with DRAP's rules on medicine advertising, indications are shared with healthcare professionals on request.
Healthcare professionals: request prescribing informationPossible Side Effects
Side effects, warnings and interactions below summarise the European product information for levetiracetam film-coated tablets (Keppra), a reference product with the same active substance and form. The Lorymed package insert approved in Pakistan is the governing document.
Very common (may affect more than 1 in 10 people)
- Common cold symptoms (nasopharyngitis)
- Sleepiness
- Headache
Common (may affect up to 1 in 10 people)
- Loss of appetite
- Depression, hostility or aggression, anxiety, insomnia, nervousness or irritability
- Convulsion, balance problems, dizziness, lethargy, tremor, vertigo
- Cough
- Stomach pain, diarrhoea, indigestion, vomiting, nausea
- Rash, weakness or tiredness
Serious effects reported (uncommon to very rare)
- Suicidal thoughts or behaviour
- Psychotic symptoms, hallucinations or abnormal behaviour
- Low blood cell counts
- Severe allergic and skin reactions (including DRESS, Stevens-Johnson syndrome)
- Liver or kidney injury, pancreatitis, muscle breakdown (rhabdomyolysis)
- Low blood sodium, QT prolongation, worsening of seizures
Not everyone gets side effects. Tell your doctor or pharmacist about any side effect, including ones not listed here.
Warnings & Precautions
Do not use
- If allergic to levetiracetam, other pyrrolidone derivatives or any other ingredient
Take special care
- Kidney problems: the dose may need adjusting
- Watch for depression, suicidal thoughts or aggressive behaviour, and seek advice promptly
- Decreased blood counts have been reported
- Do not stop treatment suddenly, because seizures may return
Pregnancy
- Specialist advice is needed before and during pregnancy
Driving
- Sleepiness may affect driving, especially early in treatment
Interactions
- Methotrexatelevels may rise to toxic values; monitor both medicines
- Macrogol (osmotic laxative)do not take by mouth from 1 hour before to 1 hour after levetiracetam
- No clinically relevant interactions reported with other antiepileptics, oral contraceptives, digoxin or warfarin
Tell your doctor or pharmacist about all medicines and supplements you take.
Storage
Store in a cool, dry and dark place. Keep out of the reach of children (pack label).
Packaging & Variants
| Variant | Strength | Dosage form | Pack |
|---|---|---|---|
| Lorymed 250 mg | 250 mg | Film-coated tablet | 10 tablets (pack label) |
| Lorymed 500 mg | 500 mg | Film-coated tablet | 3 x 10 tablets (pack label) |
Sources
Our Products
